![]() |
市場調查報告書
商品編碼
1967625
植入式循環記錄器市場 - 全球產業規模、佔有率、趨勢、機會、預測:按應用、最終用戶、地區和競爭格局分類,2021-2031年Implantable Loop Recorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球植入式循環記錄器市場預計將從 2025 年的 17.3 億美元成長到 2031 年的 28.9 億美元,複合年成長率為 8.93%。
這些小型診斷工具皮下植入,可對心律不整進行持續、長期的監測,尤其適用於心房顫動和不明原因暈厥等疾病。推動該市場發展的主要因素是全球人口老化以及需要長期觀察才能準確診斷的心律不整發病率不斷上升。此外,人們對預防中風的日益關注以及遠端患者管理系統的普及也促進了該領域的成長。根據美國心臟學會2025年的報告顯示,全球約有3,750萬人患有心房顫動,凸顯了對可靠的長期監測技術的迫切需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 17.3億美元 |
| 市場規模:2031年 | 28.9億美元 |
| 複合年成長率:2026-2031年 | 8.93% |
| 成長最快的細分市場 | 心房顫動 |
| 最大的市場 | 北美洲 |
然而,市場成長面臨一個重大障礙:這些記錄設備產生的大量數據所帶來的營運負擔。高誤報率經常擾亂臨床工作流程,需要耗費大量醫療資源進行資訊過濾和分析。此外,新興市場嚴格的報銷機制和設備高昂的初始成本也阻礙了市場滲透。這些經濟壁壘往往限制了對成本敏感地區的患者獲得這些設備的機會,從而阻礙了這些先進診斷設備的廣泛應用。
將人工智慧 (AI) 應用於進階資料分析是推動全球植入式循環記錄器市場發展的關鍵因素,尤其是在解決資料飽和問題方面。鑑於持續監測過程中產生的大量訊號給臨床人員帶來了日益繁重的工作量,AI 演算法對於過濾雜訊、突出臨床重要事件至關重要。這項技術進步透過區分真正的心律不整和偽跡,減輕了醫護人員的工作負擔,並提高了診斷準確性。例如,百多力 (Biotronik) 在 2024 年 4 月發布的新聞稿中提到,其新型 BIOMONITOR IV 的 SmartECG 技術在維持高靈敏度的同時,將主要心律不整的假陽性率降低了 86%。假陽性率的顯著降低對於擴展遠端監測能力至關重要,並使醫生能夠專注於真正的心臟事件。
同時,設備小型化技術的快速發展正在提升這些診斷設備的壽命和檢測能力,從而推動市場成長。製造商正在研發能夠在不增加設備體積的情況下延長監測時間的設備,這對於識別與不明原因中風等症狀相關的罕見心律不整至關重要。 2024年3月,雅培宣布其Assert-IQ獲得CE認證,並強調其最新植入式心臟監測儀的電池壽命超過六年,較以往標準有了顯著提升。這種耐用性使其能夠進行長期連續監測,最大限度地減少更換手術的次數,並提高患者的依從性。主要企業的財務成功反映了這些創新技術的商業性價值。 2024年11月,Medtronic心臟節律與心臟衰竭部門實現了中等個位數的內部成長,這主要得益於其監測和診斷產品的持續普及。
全球植入式循環記錄器市場成長的主要障礙在於管理大量診斷資料所帶來的工作量。這些記錄器經常產生大量與心律不整相似的假陽性訊號,因此必須由專家和技術人員進行手動評估。這種需求造成了臨床流程的瓶頸,迫使醫療團隊花費大量時間篩選無關數據,而無法專注於患者照護。由於許多醫院缺乏有效處理大量資訊的人員,這種給醫護人員帶來的負擔阻礙了該技術的廣泛應用。
此類低效率問題阻礙了遠端監測方案的擴充性,並對市場滲透率產生負面影響。 2024年,歐洲心臟學會指出,植入式心臟監測器發出的警報中約有46%為假陽性,需要行政部門確認。這種頻繁產生的數據過量增加了醫療機構的營運成本,並降低了成本敏感型市場採用該技術的經濟可行性。因此,醫療機構通常會限制新植入設備的數量,以避免現有監測部門不堪重負,從而有效地減緩了整體市場成長。
智慧型手機連接性和行動應用整合能力的提升正在改變市場格局,使笨重的床邊發送器不再必要。這項技術利用消費級技術,實現了植入式裝置與雲端臨床入口網站之間的無縫資料傳輸。透過整合藍牙功能,製造商可以提高患者依從性,並可靠地傳輸關鍵心律數據,避免傳統監測方式常見的延遲。例如,雅培公司在2024年3月發布的關於Assert-IQ設備的新聞稿中重點介紹瞭如何利用藍牙技術每20秒監測一次心律,並透過患者的行動電話將結果幾乎即時地傳輸到診所,從而使醫生能夠快速獲取關鍵數據並簡化工作流程。
同時,隨著不明原因中風診斷被納入適應症,患者族群已不再侷限於不明原因暈厥患者。醫療專業人員擴大使用這些工具來識別卒中倖存者中的無症狀房顫,這對於最佳化二級預防和抗凝血治療至關重要。臨床實務的轉變得到了強力的證據支持,即持續、長期的監測在檢測潛在心律不整方面遠比標準的外部檢測法有效。 2024年5月發表在《希臘心臟病學雜誌》上的一項研究報告稱,這些記錄設備能夠檢測到19.5%的不明原因卒中患者存在房顫,這支持了將早期納入卒中管理通訊協定的價值。
The Global Implantable Loop Recorders Market expand from USD 1.73 billion in 2025 to USD 2.89 billion by 2031 at a CAGR of 8.93%. These miniature diagnostic tools are inserted subcutaneously to provide continuous, long-term monitoring of cardiac arrhythmias, specifically for conditions like atrial fibrillation and unexplained syncope. A major force driving this market is the world's aging demographic, alongside a rising incidence of heart rhythm disorders necessitating prolonged observation for precise diagnosis. Moreover, the sector is gaining momentum due to a heightened emphasis on preventing strokes and a general transition toward remote patient management systems. As reported by the Heart Rhythm Society in 2025, atrial fibrillation impacts roughly 37.5 million people worldwide, highlighting the urgent need for dependable long-term monitoring technologies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.73 Billion |
| Market Size 2031 | USD 2.89 Billion |
| CAGR 2026-2031 | 8.93% |
| Fastest Growing Segment | Atrial Fibrillation |
| Largest Market | North America |
However, market growth faces a considerable obstacle in the form of the operational strain caused by the massive amounts of data these recorders produce. The high rate of false-positive transmissions frequently inundates clinical workflows, demanding extensive healthcare resources to filter and analyze the information. Furthermore, market penetration in emerging economies is hindered by strict reimbursement frameworks and the substantial upfront costs of the devices. These financial barriers often restrict patient access in cost-sensitive regions, limiting the widespread adoption of these sophisticated diagnostic instruments.
Market Driver
The incorporation of Artificial Intelligence for advanced data analytics has become a vital catalyst for the Global Implantable Loop Recorders Market, specifically tackling the issue of data saturation. With clinical operations under pressure from the vast quantity of signals produced during continuous monitoring, AI algorithms are crucial for eliminating noise and highlighting clinically significant events. This technological advancement relieves the workload on medical personnel and enhances diagnostic precision by distinguishing actual arrhythmias from artifacts. For instance, a Biotronik press release from April 2024 regarding their new BIOMONITOR IV noted that their SmartECG technology cuts false detections by 86% across major arrhythmias while retaining high sensitivity. Such a decrease in false positives is essential for expanding remote monitoring capabilities and keeping physician focus on authentic cardiac incidents.
Concurrently, rapid progress in device miniaturization is driving market growth by boosting the lifespan and sensing power of these diagnostic instruments. Manufacturers are developing devices that provide extended monitoring periods without enlarging their physical size, a feature vital for identifying rare arrhythmias linked to conditions like cryptogenic stroke. Abbott's March 2024 announcement regarding the CE Mark for Assert-IQ highlighted that their newest insertable cardiac monitor features a battery life exceeding six years, marking a significant improvement over earlier standards. This durability allows for prolonged continuous observation, minimizing the frequency of replacement surgeries and improving patient adherence. The financial success of leading companies reflects the commercial value of these innovations; in November 2024, Medtronic's Cardiac Rhythm & Heart Failure division posted mid-single-digit organic growth, fueled by the ongoing uptake of their monitoring and diagnostic products.
Market Challenge
A primary impediment to the growth of the Global Implantable Loop Recorders Market is the operational strain caused by managing immense quantities of diagnostic data. These recorders frequently produce a high volume of false-positive signals that resemble cardiac arrhythmias, requiring manual evaluation by specialized clinicians or technicians. This necessity leads to bottlenecks in clinical processes, compelling healthcare teams to spend disproportionate amounts of time sifting through irrelevant data instead of concentrating on patient care. The ensuing pressure on medical staff deters wider adoption, as many hospitals do not possess the workforce required to efficiently handle the influx of information.
Such inefficiencies hamper the scalability of remote monitoring initiatives and adversely affect market penetration. In 2024, the European Society of Cardiology noted that roughly 46 percent of alerts sent by implantable cardiac monitors were false positives that needed administrative review. This prevalence of superfluous data raises operational costs for healthcare providers, rendering the technology less financially feasible in markets sensitive to costs. As a result, medical institutions frequently limit the number of new device implantations to prevent overburdening their current monitoring units, effectively retarding the overall growth of the market.
Market Trends
The market is being transformed by improvements in smartphone connectivity and mobile application integration, which remove the necessity for bulky bedside transmitters. This development utilizes consumer technology to enable smooth data transmission from implantable devices directly to cloud-based clinical portals. By incorporating Bluetooth functionality, manufacturers improve patient adherence and ensure critical rhythm data is sent without the delays typical of traditional monitoring setups. For example, Abbott's March 2024 press release for the Assert-IQ device highlights its use of Bluetooth to monitor heart rhythms every 20 seconds and send results to the clinic nearly instantly via the patient's phone, streamlining workflows by giving physicians prompt access to vital data.
Concurrently, the broadening of indications to include cryptogenic stroke diagnosis is expanding the patient base beyond those with unexplained syncope. Medical professionals are increasingly using these tools to identify silent atrial fibrillation in stroke survivors, which is essential for secondary prevention and optimizing anticoagulation treatments. This shift in clinical practice is backed by strong evidence showing that continuous long-term monitoring detects occult arrhythmias much more effectively than standard external methods. A study published in the Hellenic Journal of Cardiology in May 2024 reported that these recorders detected atrial fibrillation in 19.5 percent of patients with cryptogenic stroke, confirming the value of integrating these devices earlier into stroke management protocols.
Report Scope
In this report, the Global Implantable Loop Recorders Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Implantable Loop Recorders Market.
Global Implantable Loop Recorders Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: